Drug Injury Watch

Home
United States
Wilmington, NC
Drug Injury Watch

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Drug Injury Watch, Lawyer & Law Firm, 1908 Eastwood Road , Ste. 225, Wilmington, NC.

Drug Injury Watch provides developing information about prescription drug side effects as well as up-to-date news from the legal, medical, FDA, and pharmaceutical sectors.

05/20/2026

https://drug-injury.com/2026/05/01/tavneos-drug-safety-issue-developments/

Tavneos drug safety issue development: Amgen drug label change for Tavneos VBDS liver side effect just 2 days after FDA announced possible Tavneos drug recall.

04/13/2026

https://drug-injury.com/2026/03/31/tavneos-liver-injury-drug-safety-communication/

Tavneos liver injury Drug Safety Communication issued by FDA in March 2026 re: cases of drug-induced liver injury (DILI) and vanishing bile duct syndrome (VBDS)

03/25/2026

https://drug-injury.com/2026/03/17/naion-wegovy-rate-5x-higher-than-ozempic/

NAION Wegovy rate 5x higher than NAION Ozempic rate of incidence for this vision loss side effect, and 3x higher in men than in women - Study 2026 Data Analysis

03/09/2026

https://drug-injury.com/2026/03/02/semaglutide-naion-risk-ozempic-pills-2026/

Semaglutide NAION risk remains despite name change of Novo Nordisk semaglutide pills from Rybelsus to Ozempic but new 2026 drug label does not include warnings.

02/19/2026

https://drug-injury.com/2026/02/13/risk-of-naion-with-semaglutide-medicines/

Risk of NAION with semaglutide medicines is 2-times higher than other widely used diabetes drugs says new February 2026 Ophthalmology medical journal article.

02/16/2026

https://drug-injury.com/2026/02/10/rybelsus-pancreatitis-warnings-update-2026/

Rybelsus pancreatitis death cases would be investigated as a possible drug injury lawsuit filed against the responsible pharmaceutical company, Novo Nordisk.

01/30/2026

https://drug-injury.com/2026/01/27/depo-provera-lawsuits-meningioma-warning-label-change/

Depo-Provera lawsuits can be filed in 2026 -- after the 2025 meningioma warning label change -- for women who had Depo-Provera injections before December 2025.

01/20/2026

https://drug-injury.com/2026/01/15/rybelsus-deep-vein-thrombosis-case-report/

Rybelsus deep vein thrombosis case report in 2026 medical journal article is about overweight teenage boy who used Rybelsus (semaglutide) for weight reduction.

01/07/2026

https://drug-injury.com/2026/01/02/naion-eye-side-effect-for-ozempic-and-mounjaro/

NAION eye side effect for Ozempic and Mounjaro lawsuits | December 2025 ruling keeps these lawsuits filed in federal court separate from other drug injury cases

12/23/2025

https://drug-injury.com/2025/12/15/andexxa-drug-recall-december-2025-safety-issue-blood-clots/

Andexxa drug recall in December 2025 is due in part to safety issue that involves blood clots and perhaps pulmonary embolism (PE) or deep vein thrombosis (DVT).

12/01/2025

https://drug-injury.com/2025/11/24/semaglutide-is-linked-to-naion/

Semaglutide is linked to NAION eye cases. Ozempic, Wegovy, and Rybelsus are semaglutide-containing drugs. NAION often causes sudden vision loss or blindness.

Address

1908 Eastwood Road , Ste. 225
Wilmington, NC
28403

Telephone

+18004269535

Website

http://www.druginjurywatch.com/

Alerts

Be the first to know and let us send you an email when Drug Injury Watch posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Law Practice in Wilmington?